investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Next generation bisphosphonates for chemo- and immuno-therapy
Eric Oldfield
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Tadahiko Kubo
Hiroshima University
Hiroshima, Japan
Andrew H J Wang
Academia Sinica
Taipei, Taiwan
Eric Oldfield
University of Illinois at Urbana Champaign
Urbana, United States
Related projects
Wei Zheng
Genome Sequencing to identify novel genetic factors for breast cancer risk
Breast
Global Noncommunicable Diseases Intiatives
Funding for exchange of scientists
Breast
Frank B Hu
Harvard Transdisciplinary Research in Energetics and Cancer Center
Prostate
Robert R Clarke
Collaborative Research in Integrative Cancer Biology
Breast
Charles L Loprinzi
Community Clinical Oncology Program
Breast
Pathology
Radiation Oncology
Wong-Ho Chow
Racial/ethnic disparity in breast cancer: can metabolic profiles play a role?
Breast
Mary B Terry
Genes, Environment and Breast Cancer Risk: The 15 Year Follow-Up of the Prof-SC
Breast
Ana Maria Gonzalez-Angulo
Frequency and Outcome of BRCA1/2 Mutations in Jordanian Breast Cancer Women Treated at KHCC
Breast
Jun Chung
ARRDC3-Integrin beta4 pathway as a therapeutic target of basal-like breast cancer
Breast